Encompass Health Corporation logo

Encompass Health Corporation

EHC

NYSEHealthcareMedical - Care Facilities

Previous close

$120.31

−$0.60 · -0.50%

Aug 21, 4:00 PM ET

EHC company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

84

Deep Value

Momentum

50

Neutral

Sentiment

73

Bullish

Risk resilience

72

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
Mark J. Tarr
Listed since
Sep 24, 1986
Employees
29,699

Market position

Day range

Current $120.31

52-week range

Current $120.31

Open
$121.01
Previous close
$120.91
Volume
543.41K
0.56× average
Average volume
978.71K
Average daily volume
Market cap
11.93B USD
Beta
0.6
Market reference 1
50-day average
$111.05
+8.34% above average
200-day average
$106.92
+12.52% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
13.28B USD
P/E (TTM)
19.34×
P/B (TTM)
4.58×
P/S (TTM)
1.92×
EV / EBITDA
9.46×
Earnings yield
5.31%
Free cash flow yield
4.12%
Dividend yield
0.63%

Profitability & efficiency

Gross margin
73.13%
Operating margin
18.00%
Net margin
10.01%
Return on equity
23.22%
Return on assets
7.99%
Return on invested capital
13.28%

Financial health

Debt / equity
1.09×
Current ratio
1.08×
Altman Z-score
3.46
Piotroski F-score
8 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends105%69%33%-3%Gross margin, FY2021: 42.43%Gross margin, FY2022: 40.32%Gross margin, FY2023: 41.30%Gross margin, FY2024: 41.56%Gross margin, FY2025: 95.71%Operating margin, FY2021: 16.42%Operating margin, FY2022: 14.49%Operating margin, FY2023: 35.92%Operating margin, FY2024: 16.09%Operating margin, FY2025: 17.74%Net margin, FY2021: 10.27%Net margin, FY2022: 6.23%Net margin, FY2023: 7.33%Net margin, FY2024: 8.48%Net margin, FY2025: 9.54%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 42.43%. Gross margin FY2022 40.32%. Gross margin FY2023 41.30%. Gross margin FY2024 41.56%. Gross margin FY2025 95.71%. Operating margin FY2021 16.42%. Operating margin FY2022 14.49%. Operating margin FY2023 35.92%. Operating margin FY2024 16.09%. Operating margin FY2025 17.74%. Net margin FY2021 10.27%. Net margin FY2022 6.23%. Net margin FY2023 7.33%. Net margin FY2024 8.48%. Net margin FY2025 9.54%.

Income trends

Revenue

5.94B USD+10.46%

Operating income

1.05B USD+21.82%

Net income

566.2M USD+24.25%
Income trends across reported periods6.5B USD4.24B USD1.97B USD−295.42M USDRevenue, FY2021: 4.01B USDRevenue, FY2022: 4.35B USDRevenue, FY2023: 4.8B USDRevenue, FY2024: 5.37B USDRevenue, FY2025: 5.94B USDOperating income, FY2021: 659.4M USDOperating income, FY2022: 630.2M USDOperating income, FY2023: 1.72B USDOperating income, FY2024: 864.5M USDOperating income, FY2025: 1.05B USDNet income, FY2021: 412.2M USDNet income, FY2022: 271M USDNet income, FY2023: 352M USDNet income, FY2024: 455.7M USDNet income, FY2025: 566.2M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 4.01B USD. Revenue FY2022 4.35B USD. Revenue FY2023 4.8B USD. Revenue FY2024 5.37B USD. Revenue FY2025 5.94B USD. Operating income FY2021 659.4M USD. Operating income FY2022 630.2M USD. Operating income FY2023 1.72B USD. Operating income FY2024 864.5M USD. Operating income FY2025 1.05B USD. Net income FY2021 412.2M USD. Net income FY2022 271M USD. Net income FY2023 352M USD. Net income FY2024 455.7M USD. Net income FY2025 566.2M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue5.94B USD5.37B USD4.8B USD4.35B USD4.01B USD
Cost of goods sold254.4M USD3.14B USD2.82B USD2.6B USD2.31B USD
Gross profit5.68B USD2.23B USD1.98B USD1.75B USD1.7B USD
Selling, general, and administrative3.41B USD266.5M USD258M USD209M USD228.5M USD
Operating expenses4.63B USD1.37B USD258M USD1.12B USD1.04B USD
Interest expense123.2M USD137.4M USD143.5M USD175.7M USD164.3M USD
Depreciation and amortization327.9M USD299.6M USD273.9M USD243.6M USD219.6M USD
Operating income1.05B USD864.5M USD1.72B USD630.2M USD659.4M USD
Net income566.2M USD455.7M USD352M USD271M USD412.2M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
100%
11 beats, 0 misses, 0 met estimates
Average EPS surprise
+11.10%
11 comparable reports
Latest EPS result
1.55
Estimate 1.48 · Beat by 4.73%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates1.661.441.210.99Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 6, 2025: actual 1.17, estimate 1.05, surprise +11.43%, Beat. Q2 2025, reported Apr 24, 2025: actual 1.37, estimate 1.19, surprise +15.13%, Beat. Q3 2025, reported Aug 5, 2025: actual 1.4, estimate 1.23, surprise +13.82%, Beat. Q4 2025, reported Oct 29, 2025: actual 1.23, estimate 1.19, surprise +3.36%, Beat. Q1 2026, reported Feb 5, 2026: actual 1.46, estimate 1.29, surprise +13.18%, Beat. Q2 2026, reported Apr 30, 2026: actual 1.6, estimate 1.51, surprise +5.96%, Beat. Q3 2026, reported Aug 5, 2026: actual 1.55, estimate 1.48, surprise +4.73%, Beat. Q4 2026, reported Oct 28, 2026: actual —, estimate 1.38, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates1.67B1.55B1.43B1.32BQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 6, 2025: actual 1.41B USD, estimate 1.38B USD, surprise +1.72%, Beat. Q2 2025, reported Apr 24, 2025: actual 1.46B USD, estimate 1.43B USD, surprise +1.80%, Beat. Q3 2025, reported Aug 5, 2025: actual 1.46B USD, estimate 1.43B USD, surprise +2.13%, Beat. Q4 2025, reported Oct 29, 2025: actual 1.48B USD, estimate 1.48B USD, surprise -0.22%, Miss. Q1 2026, reported Feb 5, 2026: actual 1.54B USD, estimate 1.54B USD, surprise +0.33%, Beat. Q2 2026, reported Apr 30, 2026: actual 1.59B USD, estimate 1.57B USD, surprise +1.21%, Beat. Q3 2026, reported Aug 5, 2026: actual 1.6B USD, estimate 1.57B USD, surprise +1.66%, Beat. Q4 2026, reported Oct 28, 2026: actual —, estimate 1.6B USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

27 ratings
Strong buy14%
Buy2178%
Hold415%
Sell14%
Strong sell00%

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$0.70

2025 complete year-21.4% since 2020

2026 partial: $0.57

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Oct 1, 2026

$0.21

Quarterly

Record Oct 1, 2026 · Payment Oct 15, 2026

Dividend

Ex-dividend Jul 1, 2026

$0.19

Quarterly

Record Jul 1, 2026 · Payment Jul 15, 2026

Dividend

Ex-dividend Apr 1, 2026

$0.19

Irregular

Record Apr 1, 2026 · Payment Apr 15, 2026

Dividend

Ex-dividend Jan 2, 2026

$0.19

Quarterly

Record Jan 2, 2026 · Payment Jan 15, 2026

Dividend

Ex-dividend Oct 1, 2025

$0.19

Quarterly

Record Oct 1, 2025 · Payment Oct 15, 2025

Dividend

Ex-dividend Jul 1, 2025

$0.17

Quarterly

Record Jul 1, 2025 · Payment Jul 15, 2025

EHC peers

ETFs holding EHC

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research EHC

research.disclaimer